Literature DB >> 9398494

Lack of embryotoxicity of fumonisin B1 in New Zealand white rabbits.

J B LaBorde1, K K Terry, P C Howard, J J Chen, T F Collins, M E Shackelford, D K Hansen.   

Abstract

Fumonisin B1 (FB1) is one of a number of mycotoxins produced by fungi, especially Fusarium sp. As a contaminant of many maize-derived products, this toxin is associated with a variety of animal diseases, including esophageal cancer and possibly neural tube defects in humans. We have investigated the embryotoxic potential of this compound in New Zealand White rabbits. Animals were dosed by gavage daily on GD 3-19 with purified FB1 at 0.10, 0.50, or 1.00 mg/kg/day. Maternal lethality occurred at the 0.50 and 1.00 mg/kg/day doses. When examined on GD 29, there were no differences in maternal body weight, maternal weight gain, maternal organ weights, number of nonlive implantations, and number of malformations. Fetal weight was decreased at 0.50 and 1.00 mg/kg/day (13 and 16%, respectively); this was true for male and female pups. Fetal liver and kidney weights were also decreased at these doses. Analysis of embryonic sphinganine to sphingosine ratios demonstrated no differences between control and treated embryos on GD 20, although these ratios were increased in maternal urine, serum, and kidney when compared to control animals. These data suggest that FB1 did not cross the placenta and that the observed decreased fetal weight was probably the result of maternal toxicity, rather than any developmental toxicity produced by FB1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398494     DOI: 10.1006/faat.1997.2380

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  8 in total

Review 1.  The role of dihydrosphingolipids in disease.

Authors:  Ruth R Magaye; Feby Savira; Yue Hua; Darren J Kelly; Christopher Reid; Bernard Flynn; Danny Liew; Bing H Wang
Journal:  Cell Mol Life Sci       Date:  2018-12-06       Impact factor: 9.261

2.  Morphology and Chemical Coding of Rat Duodenal Enteric Neurons following Prenatal Exposure to Fumonisins.

Authors:  Katarzyna Kras; Halyna Rudyk; Siemowit Muszyński; Ewa Tomaszewska; Piotr Dobrowolski; Volodymyr Kushnir; Viktor Muzyka; Oksana Brezvyn; Marcin B Arciszewski; Ihor Kotsyumbas
Journal:  Animals (Basel)       Date:  2022-04-19       Impact factor: 3.231

3.  Fumonisins: current research trends in developmental toxicology.

Authors:  K A Voss; J B Gelineau-van Waes; R T Riley
Journal:  Mycotoxin Res       Date:  2006-03       Impact factor: 3.833

4.  Physiological response of rabbit bucks to dietary fumonisin: performance, haematology and serum biochemistry.

Authors:  Emmanuel O Ewuola; Francis A Gbore; Jacob T Ogunlade; Ranajit Bandyopadhyay; John Niezen; Gabriel N Egbunike
Journal:  Mycopathologia       Date:  2008-02-12       Impact factor: 2.574

Review 5.  An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme.

Authors:  K A Voss; R T Riley; W P Norred; C W Bacon; F I Meredith; P C Howard; R D Plattner; T F Collins; D K Hansen; J K Porter
Journal:  Environ Health Perspect       Date:  2001-05       Impact factor: 9.031

Review 6.  Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.

Authors:  R T Riley; E Enongene; K A Voss; W P Norred; F I Meredith; R P Sharma; J Spitsbergen; D E Williams; D B Carlson; A H Merrill
Journal:  Environ Health Perspect       Date:  2001-05       Impact factor: 9.031

Review 7.  Developmental Toxicity of Mycotoxin Fumonisin B₁ in Animal Embryogenesis: An Overview.

Authors:  Chompunut Lumsangkul; Hsin-I Chiang; Neng-Wen Lo; Yang-Kwang Fan; Jyh-Cherng Ju
Journal:  Toxins (Basel)       Date:  2019-02-13       Impact factor: 4.546

8.  Evaluation of sphingolipids in Wistar rats treated to prolonged and single oral doses of fumonisin b₁.

Authors:  Glória M Direito; Adriana P Almeida; Simone Aquino; Tatiana Alves Dos Reis; Claudia Rodrigues Pozzi; Benedito Corrêa
Journal:  Int J Mol Sci       Date:  2008-12-27       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.